Skip to main content
Clinical Trials/EUCTR2019-001016-35-DK
EUCTR2019-001016-35-DK
Active, not recruiting
Phase 1

The ultrasound-guided multiple-injection costotransverse block for mastectomy and primary reconstructive surgery. A double blind, randomised, placebo controlled trial.

Associate Professor, Consultant Jens Børglum0 sites36 target enrollmentMarch 14, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Postoperative pain following mastectomy and reconstructive surgery due to breast cancer.
Sponsor
Associate Professor, Consultant Jens Børglum
Enrollment
36
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 14, 2019
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Associate Professor, Consultant Jens Børglum

Eligibility Criteria

Inclusion Criteria

  • Scheduled for elective unilateral mastectomy and primary reconstructive surgery (UMPR) with subpectoral implant due to breast cancer
  • Age above/equal to 18 years at the date of inclusion
  • Have received thorough information, orally and in written, and signed the Informed Consent” form on participation in the study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 30
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 6

Exclusion Criteria

  • Scheduled for elective UMPR surgery due to breast cancer combined with simultaneous contralateral major breast surgery (mastectomy, mastopexy and subpectoral breast reconstruction). Minor contralateral surgery (e.g. lipofilling) are accepted.
  • Scheduled free flap reconstructive surgery
  • Inability to cooperate
  • Inability to speak, read and understand Danish
  • Allergy to local anaesthetics or opioids
  • Daily intake of opioids, according to the investigators decision
  • Illegal drug and/or substance abuse, according to the investigators decision
  • Local infection at the site of injection or systemic infection
  • Difficult sonoanatomical visualisation of the target area necessary for the block execution
  • Substantial co\-morbidity, ASA\>3

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.Breast CancerDuctal Carcinoma in Situ
NCT04248179Zealand University Hospital36
Not yet recruiting
Phase 3
Comparing the effectiveness of ultrasound guided different approaches of pain relief in hand and forearm surgeriesHealth Condition 1: O- Medical and Surgical
CTRI/2024/04/065031All India Institute of Medical Sciences
Not yet recruiting
Phase 4
Comparison between ultrasound guided triamcinolone (steroid) injection in sacroiliac joint (a joint in the lower back) and oral Etoricoxib (a painkiller) in patients with spondyloarthritisHealth Condition 1: M458- Ankylosing spondylitis sacral andsacrococcygeal regionHealth Condition 2: M458- Ankylosing spondylitis sacral andsacrococcygeal region
CTRI/2024/07/069736INSTITUTE OF NEUROSCIENCES KOLKATA
Completed
Not Applicable
A novel technique of The Ultrasound- guided Costotransverse Foramen block: Difference in the spread of injectate between Costotransverse foramen and Erector Spinae Plane block. Cadaveric studyovel technique for paravertebral blockCostotransverse foramen block&#44Erector spinae plane block&#44Paravertebral space&#44Ultrasound guided&#44Cadaveric study
TCTR20190205004King Chulalongkorn Memorial Hospital and Faculty of medicine, Chulalongkorn University6
Not yet recruiting
Phase 3
Comparison of the effects of hyaluronic acid and hyaluronidase injection in carpal tunnel syndrome
IRCT20170311033000N5Research Assistant of Shahid Beheshti University of Medical Sciences90